Publication:
Efficacy and safety of ibrutinib use in patients with chronic lymphocytic leukemia in real world experiences: Results of a prospective multicenter study

Simple item page
dc.contributor.authorTombak, Anıl
dc.contributor.authorTanrıkulu, Funda Pepedil
dc.contributor.authorDurusoy, Salih Sertaç
dc.contributor.authorGürkan, Emel
dc.contributor.authorKaya, Emin
dc.contributor.authorUmit, Elif G.
dc.contributor.authorYavaşoğlu, İrfan
dc.contributor.authorMehtap, Özgür
dc.contributor.authorDeveci, Burak
dc.contributor.authorÖzcan, Mehmet Ali
dc.contributor.authorTerzi, Hatice
dc.contributor.authorOkay, Mufide
dc.contributor.authorSayınalp, Nilgün
dc.contributor.authorYılmaz, Mehmet
dc.contributor.authorOkan, Vahap
dc.contributor.authorKızıklı, Alperen
dc.contributor.authorÖzcan, Ömer
dc.contributor.authorÇetin, Guven
dc.contributor.authorDemircioglu, Sinan
dc.contributor.authorAydogdu, Ismet
dc.contributor.authorSaydam, Guray
dc.contributor.authorDavulcu, Eren Arslan
dc.contributor.authorİlhan, Gul
dc.contributor.authorUcar, Mehmet Ali
dc.contributor.authorÖzet, Gulsum
dc.contributor.authorAkpinar, Seval
dc.contributor.authorTurgut, Burhan
dc.contributor.authorBerber, İlhami
dc.contributor.authorKurtoglu, Erdal
dc.contributor.authorSonmez, Mehmet
dc.contributor.authorBatur, Derya Selim
dc.contributor.authorYildirim, Rahsan
dc.contributor.authorÖzkocaman, Vildan
dc.contributor.authorGunes, Ahmet Kursat
dc.contributor.authorSahip, Birsen
dc.contributor.authorErtop, Sehmus
dc.contributor.authorAkay, Meltem
dc.contributor.authorBasturk, Abdulkadir
dc.contributor.authorDogu, Mehmet Hilmi
dc.contributor.authorAkdeniz, Aydan
dc.contributor.authorÜnal, Ali
dc.contributor.authorSeyhanli, Ahmet
dc.contributor.authorFerhanoglu, Burhan
dc.contributor.buuauthorÖZKOCAMAN, VİLDAN
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentHematoloji Ana Bilim Dalı
dc.contributor.researcheridAAH-1854-2021
dc.date.accessioned2024-12-04T13:10:57Z
dc.date.available2024-12-04T13:10:57Z
dc.date.issued2019-11-13
dc.descriptionBu çalışma, 07-10 Aralık, 2019 tarihlerinde Orlando[Amerika]’da düzenlenen 61. Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) Kongresi‘nde bildiri olarak sunulmuştur.
dc.description.sponsorshipAmer Soc Hematol
dc.identifier.doi10.1182/blood-2019-126402
dc.identifier.eissn1528-0020
dc.identifier.issn0006-4971
dc.identifier.urihttps://doi.org/10.1182/blood-2019-126402
dc.identifier.urihttps://ashpublications.org/blood/article/134/Supplement_1/5476/425188/Efficacy-and-Safety-of-Ibrutinib-Use-in-Patients
dc.identifier.urihttps://hdl.handle.net/11452/48891
dc.identifier.volume134
dc.identifier.wos000577164606194
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherAmer Soc Hematology
dc.relation.journalBlood
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectHematology
dc.titleEfficacy and safety of ibrutinib use in patients with chronic lymphocytic leukemia in real world experiences: Results of a prospective multicenter study
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Hematoloji Ana Bilim Dalı
relation.isAuthorOfPublication516d4442-e436-45a6-87b9-741a9e213d31
relation.isAuthorOfPublication.latestForDiscovery516d4442-e436-45a6-87b9-741a9e213d31

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Özkocaman_vd_2019.pdf
Size:
264.42 KB
Format:
Adobe Portable Document Format
Download

Collections

İndeksli Yayınlar / Indexed Publications